Melanoma News

An International Placebo-Controlled Comparative Randomized Trial of Efficacy and Safety of Sequential BCD-217 and BCD-100 Therapy Compared to BCD-100 Monotherapy as First-Line Treatment in Patients With Unresectable or Metastatic Melanoma

An International Placebo-Controlled Comparative Randomized Trial of Efficacy and Safety of Sequential BCD-217 and BCD-100 Therapy Compared to BCD-100 Monotherapy as First-Line Treatment in Patients With Unresectable or Metastatic Melanoma

Melanoma News
Publication date: Apr 12, 2019 This is a multicenter randomized double-blind placebo-controlled phase II clinical trial. The purpose of this trial is to evaluate efficacy and safety of therapy consisting ... Read more